Amgen Inc
AMGN
Revenue
8.50B
▲115.00M▲1.37%
3 Months ChangeAssets
90.88B
▼-24.00M▼-0.02640%
3 Months ChangeLiabilities
83.36B
▼-1.63B▼-1.91%
3 Months ChangeFree Cash Flow
459.00M
▼-261.00M▼-36.25%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0000318154-24-000044
2024-10-30
Form 8-K
ID: 0000318154-24-000042
2024-08-07
Form 10-Q
ID: 0000318154-24-000035
2024-08-06
Form 8-K
ID: 0000318154-24-000033
2024-06-03
Form 8-K
ID: 0001193125-24-153221
2024-05-03
Form 10-Q
ID: 0000318154-24-000020
2024-05-02
Form 8-K
ID: 0000318154-24-000018
2024-02-06
Form 8-K
ID: 0000318154-24-000004
2023-12-14
Form 8-K
ID: 0001193125-23-295027
2023-10-31
Form 10-Q
ID: 0000318154-23-000064